Atrium Therapeutics, Inc.: updates and filings

RNANASDAQHealthcare · Pharmaceutical PreparationsNew listingsince Feb 26, 2026

Price

$6.92

November 20, 2026Market cap $149M

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 82 daysAround Feb 12, 2027 · for Q4 2026

last Nov 12, 2026next Feb 12, 2027

A rough estimate from when it has reported before, which has varied. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Nov 12, 2026 latest quarterly
  • Nov 16, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Nov 12, 2026Quarterly reportfor the period to Sep 30, 2026
    Form10-Q
  • Nov 12, 2026Results of operations
    Form8-K
  • Nov 2, 2026Regulation FD disclosure, other material events
    Form8-K
  • Oct 27, 2026Other material events
    Form8-K
  • Oct 9, 2026Other material events (amendment)
    Form8-K/A
  • Oct 8, 2026Material agreement entered, unregistered sale of shares, other material events
    Form8-K
  • Aug 14, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Aug 14, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Aug 14, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Aug 13, 2026Quarterly reportfor the period to Jun 30, 2026
    Form10-Q
  • Aug 13, 2026Results of operations
    Form8-K
  • Jul 27, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Jul 14, 2026Other material events
    Form8-K
  • May 15, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • May 14, 2026Quarterly reportfor the period to Mar 31, 2026
    Form10-Q
  • May 14, 2026Results of operations
    Form8-K
  • Apr 27, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Apr 17, 2026Shares registered for employees
    FormS-8
  • Apr 8, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Feb 27, 2026Material agreement entered, change in control, officer or director change
    Form8-K
  • Feb 26, 2026Regulation FD disclosure
    Form8-K
  • Feb 26, 2026Shares registered for employees
    FormS-8
  • Feb 26, 2026Filing
    FormSEC STAFF ACTION
  • Feb 26, 2026Exchange certification of a listing
    FormCERT

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Dec 10, 2025.

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.